APA (7th ed.) Citation

Blokhina, N. P., Nurmuhametova, E. A., Rusanova, M. G., Gagarina, I. V., Mar’jamova, E. S., Kuznetsova, N. A., . . . Morozova, M. A. The efficacy and safety of double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alfa 2b and ribavirin) treatment regimens in chronic hepatitis C patients. The experience of everyday clinical practice. Journal Infectology.

Chicago Style (17th ed.) Citation

Blokhina, N. P., et al. The Efficacy and Safety of Double (cepeginterferon Alfa-2b and Ribavirin) and Triple (simeprevir, Cepeginterferon Alfa 2b and Ribavirin) Treatment Regimens in Chronic Hepatitis C Patients. The Experience of Everyday Clinical Practice. Journal Infectology.

MLA (9th ed.) Citation

Blokhina, N. P., et al. The Efficacy and Safety of Double (cepeginterferon Alfa-2b and Ribavirin) and Triple (simeprevir, Cepeginterferon Alfa 2b and Ribavirin) Treatment Regimens in Chronic Hepatitis C Patients. The Experience of Everyday Clinical Practice. Journal Infectology.